Examination of systemic tumor necrosis factor activity under physiological and pathophysiological conditions;Untersuchungen zur systemischen Tumor-Nekrose-Faktor-Aktivität unter physiologischen und pathophysiologischen Bedingungen

Berliner und Munchener Tierarztliche Wochenschrift

Volumn 112, Issue 3, 1999, Pages 91-97

  Kretzschmar, Carolin ^a   Krüger, Monika ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Age relation; Cattle; Diseases; Dogs; Horses; Pigs; TNF activity; Tumor necrosis factor (TNF)

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

AGING; ANIMAL; ARTICLE; BIOASSAY; BLOOD; CATTLE; CATTLE DISEASE; DOG; FEMALE; HORSE; L CELL; MALE; METABOLISM; METHODOLOGY; MOUSE; PHYSIOLOGY; REFERENCE VALUE; SPECIES DIFFERENCE; SWINE;

AGING; ANIMALS; BIOLOGICAL ASSAY; CATTLE; CATTLE DISEASES; DOGS; FEMALE; HORSES; L CELLS (CELL LINE); MALE; MICE; REFERENCE VALUES; SPECIES SPECIFICITY; SWINE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033088934     PISSN: 00059366     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Adams, J. L., S. D. Semrad, C. J. Czuprynski (1990): Administration of bacterial lipopolysaccharide elicits circulating tumor necrosis factor-alpha in neonatal calves. J. Clin. Microbiol. 28, 998-1001.
2. Aderka, D., H. Engelmann, D. Wallach (1993): Soluble Tumor Necrosis Factor Receptors in Health and Disease. In Fiers, W., W. A. Buurman (Eds.): Tumor Necrosis Factor: Molecular and Cellular Biology and Clinical Relevance. Basel: S. Karger, 191-198.
3. Aggarwal, B. B. (1987): Tumor necrosis factors - TNF-α and TNF-β: their structure and pleiotropic biological effects. Drugs of the future 12, 891-898.
4. Allen, G. K., E. M. Green, J. A. Robinson, H. E. Garner, W. E. Loch, D. M. Walsh (1993): Serum tumor necrosis factor alpha concentrations and clinical abnormalities in colostrum-fed and colostrum-deprived neonatal foals given endotoxin. Am. J. Vet. Res. 54, 1404-1410.
5. Andus, T., P. C. Heinrich, J. C. Castell, W. Gerok (1989): Interleukin-6: ein Schlüsselhormon der Akutphase-Reaktion. Dtsch. Med. Wschr. 114, 1710-1716.
6. Arnold, R., J. Scheffer, B. König, W. König (1993): Effects of Listeria monocytogenes and Yersinia enterocolitica on cytokine gene expression and release from human polymorphonuclear granulocytes and epithelial (HEp-2) cells. Infect. Immun. 61, 2545-2552.
7. Bertoni, G., P. Kuhnert, E. Peterhans, U. Pauli (1993): Improved bioassay for the detection of porcine tumor necrosis factor using a homologous cell line: PK(15). J. Immunol. Methods. 160, 267-271.
8. Beutler, B., W. Milsark, A. Cerami (1985): Cachectin / tumor necrosis factor: production, distribution, and metabolic fate in vivo. J. Immunol. 135, 3972-3977.
9. De Vries, I., S. J. H. Van Deventer, J. Debets, H. R. Buller, J. W. ten Cate, W. Pauw, L. W. S. Van Eps, A. Sturk (1990): Endotoxin-induced cytokines in human septicemia. Advanc. Exp. Med. Biol. 256, 635-640.
10. Döcke, W. D., U. Syrbe, A. Meinecke, C. Platzer, A. Makki, K. Asadulla, C. Klug, H. Zuckermann, P. Reinke, H. Brunner, R. von Baehr, H.-D. Volk (1994): Verbesserte Monozytenfunktion - ein neuer Therapieansatz? Sepsis 18, 473-488.
11. Fiers, W. (1991): Tumor necrosis factor. Characterisation at the molecular, cellular and in vivo level. FEBS Letters 285, 199-212.
12. Flick, D. A., G. E. Gifford (1984): Comparison of in vitro cell cytotoxic assays for tumor necrosis factor. J. Immunol. Methods 68, 167-175.
13. Fong, Y. M., S. F. Lowry (1990): Tumor necrosis factor in the pathophysiology of infection and sepsis. Clin. Immunol. Immunopathol. 55, 157-170.
14. Freudenberg, M. A., T. Neß, Y. Kumazawa, C. Galanos (1993): Die Bedeutung von Zytokinen beim Endotoxinschock und bei der Endotoxinüberempfindlichkeit. Immun. Infekt. 21, 40-44.
15. Green, I. R., C. Fiskerstrand, G. Bertoni, D. J. Roy, E. Peterhans, D. R. Sargan (1993): Expression and characterization of bioactive recombinant ovine TNF-α: Some species specifity in the cytotoxic response to TNF. Cytokine 5, 213-223.
16. Hack, C. E., E. R. De Groot, R. J. F. Felt-Bersma, J. H. Nuijens, R. J. M. Strack Van Schijndel, A. J. M. Eerenberg-Belmer, L. G. Thijs, L. A. Aarden (1989): Increased plasma levels of interleukin-6 in sepsis. Blood 74, 1704-1710.
17. Jilg, S., A. Wendel (1994): Protection from LPS by xanthine derivates is accompanied by a modulated cytokine response. Immunobiol. 191, 178.
18. Le May, D. R., L. G. Le May, M. J. Kluger, L. G. D'Alecy (1990): Plasma profiles of IL-6 and TNF with fever-inducing doses of lipopolysaccharide in dogs. Am. J. Physiol. 259, R126-132.
19. Mac Kay, R. J., A. M. Merritt, J. M. Zertuche, M. Whittington, B. S. Skelley (1991): Tumor necrosis factor activity in the circulation of horses given endotoxin. Am. J. Vet. Res. 52, 533-538.
20. Munoz, C., J. Carlet, C. Fitting, B. Misset, J.-P. Bleriot, J.-M. Cavaillon (1991): Dysregulation of in vitro cytokine production by monocytes during sepsis. J. Clin. Invest. 88, 1747-1754.
21. Pauli, U., G. Bertoni, M. Duerr, E. Peterhans (1994): A bioassay for the detection of tumor necrosis factor from eight different species: Evaluation of neutralization rates of a monoclonal antibody against human TNF-α. J. Immunol. Methods 171, 263-265.
22. Ramachandra, R. N., A. Berczi, A. H. Sehon, I. Berczi (1993): Inhibition of lipid A- and lipopolysaccharide-induced cytokine secretion, B cell mitogenesis, and lethal shock by lipid A-specific murine monoclonal antibodies. J. Infect. Dis. 167, 1151-1159.
23. Robinson, J. A., G. K. Allen, E. M. Green, H. E. Garner, W. E. Loch, D. M. Walsh (1993): Serum interleukin-6 concentrations in endotoxin-infused neonatal foals. Am. J. Vet. Res. 54, 1411-1414.
24. Ruff, M. R., G. E. Gifford (1981): Tumor necrosis factor. Lymphokines 2, 235-272.
25. Schade, U. F., M. Ernst, M. Reinke, D. T. Wolter (1989): Lipoxygenase inhibitors suppress formation of tumor necrosis factor in vitro and in vivo. Biochem. Biophys. Res. Comm. 159, 748-754.
26. Sordillo, L. M., J. E. Peel (1992): Effect of interferon γ-on the production of tumor necrosis factor during acute Escherichia coli mastitis. J. Dairy Sci. 75, 2119-2125.
27. Sordillo, L. M., G. M. Pighetti, M. R. Davis (1995): Enhanced production of bovine tumor necrosis factor α during the periparturient period. Vet. Immunol. Immunopathol. 49, 263-270.
28. Takahashi, G. W., R. B. Montgomery, W. L. Stahl, C. A. Crittenden, M. A. Valentine, D. R. Thorning, D. F. Andrews, M. B. Lilly (1994): Pentoxifylline inhibits tumor necrosis factor-α mediated cytotoxicity and cytostasis in L929 murine fibrosarcoma cells. Int. J. Immunopharmac. 16, 723-736.
29. Vassalli, P. (1992): The pathophysiology of tumor necrosis factors. Annu. Rev. Immunol. 10, 411-452.
30. Volk, H.-D., D. Krausch, W. D. Döcke, S. N. Kox, H. Wauer, K. Egerer, S. Querner, K. Asadullah, R. von Baehr, W. J. Kox (1996): Interferon-gamma in the treatment of "immunoparalysis" - a new therapeutic approach to sepsis? Results of an open-label phase I/II trial. Paper, Workshop "Role of CD14 in health and disease", Insel Vilm, 13.-15.7.1996.
31. Waage, A. (1992): Presence and involvement of TNF in septic shock. In Beutler, B. (Ed.): Tumor Necrosis Factors. The Molecules and Their Emerging Role in Medicine. New York: Raven, 275-284.
32. Whicher, J., E. Ingham (1990): Cytokine measurement in body fluids. Eur. Cytokine. Net. 1, 239-243.